Drug coupons – a pharma company’s best friend

Earlier this week, Health Care For All testified before the Joint Committee on Financial Services in opposition to a bill that would allow the pharmaceutical industry to market “coupons” for brand name drugs.  This bill is one among many before the Massachusetts legislature that would open up a whole new marketing ploy for the pharma and medical device industry.

As consumer advocates, we at HCFA see drug coupons as nothing more than a tactic to entice consumers into purchasing more expensive brand-name drugs, when cheaper and equally-effective generics are available.

Drug companies provide coupons in limited quantities and only for expensive name-brand drugs.  As soon as the coupons run out, consumers are forced to pay the high co-pay out of pocket for the duration of the prescription.  In some cases, they may need to take that drug for many years.  In the end, individuals are left with higher out-of-pocket costs, and the drug companies benefit by selling more of their most expensive drugs. If drug companies are serious about helping consumers afford drugs they need, they should simply reduce the drug price.

The health care system as a whole also incurs higher costs when drug coupons are utilized.  Because insurance companies pay the entire of cost of a prescription drug minus the co-payment, drug costs are significantly more when consumers choose to purchase a name-brand rather than a generic prescription drug solely because of a coupon.  In the long-run, this doesn’t benefit consumers but rather leads to increased insurance co-pays and premium costs for everyone.

For an account of how this plays out in the real world, listen to the story presented in this fabulous This American Life report of how a young man was lured by drug coupons into purchasing an acne drug that costs over $600 more than the generic version. NPR’s Planet Money reporter calls drug coupons part of an escalating arms race, as the drug industry tries every way possible to market its high-margin drugs directly to patients.

Coupons are already banned by Medicare and Medicaid, and the Commonwealth’s longstanding policy in this area should be maintained.  Legalizing drug coupons in Massachusetts would represent a significant step backwards in our efforts to control prescription drug costs.

Cost is the most significant health care issue facing the Legislature and the Commonwealth today. There’s no question that allowing drug coupons would raise costs. Look at the experience of Union College, which experienced soaring drug costs when coupons expanded:

Beforehand, CDPHP [their health plan] spent roughly $500,000 each year for this class of antibiotic drugs. But by the first quarter in 2008, less than six months after the coupon was introduced, costs soared to $1.2 million, says Eileen Wood, vice president of pharmacy and quality programs at the plan.

CDPHP’s cost for a one-month’s supply of Solodyn, she says, was $500 with a $50 co-pay, compared to $40 a month with a $10 co-pay for the generic version — which fewer people used because of the coupon.

“They’re problematic because they do increase costs, which carries over, not only to the employer, but to the employee as well,” [benefit director Eric Noll] adds. “Employees will end up paying a higher premium than they need to and the plan ends up paying a much higher cost. In the long run, everybody loses.”

As we all wrestle with how to get escalating insurance premiums under control, it is important that we not lose sight of the progress we have made in addressing the ways in which pharmaceutical and medical device marketing can drive costs up health care costs.  Massachusetts should not take a step backwards in this fight.
-Alyssa Vangeli

About HCFA

The Ultimate Massachusetts Health Care Insider Information
This entry was posted in Healthcare Cost Control, Prescription Drug Reform. Bookmark the permalink.

3 Responses to Drug coupons – a pharma company’s best friend

  1. Beth says:

    This is a good example of anti-pharma policy gone bad. Massachusetts already has the largest percentage of generic presciptions in the US. The reason why is the physicians are paid by the insurance companies like Blue Cross Blue Shield of Mass (this practice is illegal in some states by the way) to prescribe generics more often. These coupons will not result in a greater amount of branded prescriptions- the kickbacks prevent this. What it does do, is it helps patients who cannot afford their copays. Why should MS patients in RI pay zero in copay, while the same patient in Massachusetts pays alot? So BCBS can have a higher profit margin?

    Unfortunately, brand name drugs are too expensive, but often necessay. Let’s let the patients get this benefit instead of choosing copays over groceries. The coupons have zero effect on the cost of medicine, or the utilization of generics.

    • fender says:

      Correct , if used correctly coupons provide intial low cost trials of expensive medication AFTER generics have failed or have side effects. HCFA seems to want to elimiate all options for the providers & patients with this anti-pharma message, that has big unintended consequences they dont understand for the patients, MDs and the Ecom of Boston. Medicine in not practiced in a ivory tower of ideology, it is praticed in the real world. More regulations eliminate options & hinder progress

  2. fender says:

    Coupons are used when generics fail or have side effects. Patients are not “forced” to continue with the medication. The coupons allow patients to try the more expensive non generic medication at a discount, or free for the 1st month to see if side effects still occur or that it works or makes clinical goals better than the non generic. Otherwise the pt would then be ‘forced’ to pay full price to try the new medication after the generic has failed. Stop with the negative phama rhetoric all the time, MA had already overregulated itself into oblivion with NO cost benefit to show for it as it has some of the highest medical cost in the country despite HCFA broken record mentality that more government regulations is the panacea for cost control: Its not

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s